190 filings
Page 6 of 10
S-8
IMAB
I-Mab
28 May 21
Registration of securities for employees
4:01pm
6-K
IMAB
I-Mab
20 May 21
I-Mab Announces First Patient Dosed in China Phase 2 Combination Trial of Lemzoparlimab with Azacitidine in Patients
6:10am
424B3
IMAB
I-Mab
30 Apr 21
Prospectus supplement
4:03pm
20-F
2020 FY
IMAB
I-Mab
Annual report (foreign)
28 Apr 21
7:47am
6-K
IMAB
I-Mab
28 Apr 21
I-Mab Announces Positive Topline Phase 2 Results for Olamkicept in Ulcerative Colitis
6:49am
6-K
IMAB
I-Mab
7 Apr 21
Current report (foreign)
12:04pm
6-K
IMAB
I-Mab
29 Mar 21
I-Mab Reports Financial Results for Full Year of 2020
4:03pm
SC 13D/A
IMAB
I-Mab
25 Mar 21
I-Mab / HILLHOUSE CAPITAL ADVISORS ownership change
4:25pm
EFFECT
IMAB
I-Mab
24 Mar 21
Notice of effectiveness
12:15am
424B3
IMAB
I-Mab
19 Mar 21
Prospectus supplement
4:04pm
POS AM
IMAB
I-Mab
19 Mar 21
Prospectus update (post-effective amendment)
4:01pm
SC 13G
IMAB
I-Mab
16 Feb 21
I-Mab / Tasly Biopharmaceuticals ownership change
4:01pm
SC 13G
IMAB
I-Mab
16 Feb 21
I-Mab / Genexine ownership change
8:01am
SC 13G
IMAB
I-Mab
12 Feb 21
I-Mab / CBC Investment I-Mab ownership change
7:35am
SC 13G/A
GIC Private Ltd
10 Feb 21
I-Mab / GIC Private ownership change
4:05pm
424B5
IMAB
I-Mab
9 Feb 21
Prospectus supplement for primary offering
4:05pm
6-K
IMAB
I-Mab
9 Feb 21
Registered Secondary Public Offering of American Depositary Shares by Certain Pre-IPO Shareholders of I-Mab Has Priced
8:15am
SC 13G
Jingwu Zhang Zang
9 Feb 21
I-Mab / Zang Jingwu Zhang ownership change
6:45am
6-K
IMAB
I-Mab
8 Feb 21
Current report (foreign)
4:01pm
424B5
IMAB
I-Mab
8 Feb 21
Prospectus supplement for primary offering
12:00am